Eton Pharmaceuticals, Inc. (ETON)
ETON Stock Price Chart
Explore Eton Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ETON price movements and trends.
ETON Company Profile
Discover essential business fundamentals and corporate details for Eton Pharmaceuticals, Inc. (ETON) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Nov 2018
Employees
31.00
Website
https://www.etonpharma.comCEO
Sean E. Brynjelsen
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
ETON Financial Timeline
Browse a chronological timeline of Eton Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is $0.13.
Earnings released on 7 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $18.93M , missing expectations by -7.55%.
Earnings released on 13 May 2025
EPS came in at $0.07 falling short of the estimated $0.09 by -22.22%, while revenue for the quarter reached $17.28M , beating expectations by +14.22%.
Earnings released on 18 Mar 2025
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $11.65M , missing expectations by -18.73%.
Earnings released on 12 Nov 2024
EPS came in at $0.02 surpassing the estimated $0.00 by +400.00%, while revenue for the quarter reached $10.32M , missing expectations by -1.96%.
Earnings released on 8 Aug 2024
EPS came in at -$0.12 falling short of the estimated -$0.07 by -71.43%, while revenue for the quarter reached $9.07M , missing expectations by -6.36%.
Earnings released on 9 May 2024
EPS came in at -$0.03 surpassing the estimated -$0.07 by +57.14%, while revenue for the quarter reached $7.97M , missing expectations by -9.48%.
Earnings released on 14 Mar 2024
EPS came in at -$0.09 falling short of the estimated -$0.04 by -125.00%, while revenue for the quarter reached $7.31M , missing expectations by -5.03%.
Earnings released on 9 Nov 2023
EPS came in at -$0.02 surpassing the estimated -$0.10 by +80.00%, while revenue for the quarter reached $7.03M , beating expectations by +12.27%.
Earnings released on 10 Aug 2023
EPS came in at $0.15 surpassing the estimated -$0.09 by +266.67%, while revenue for the quarter reached $12.00M , beating expectations by +18.90%.
Earnings released on 11 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $5.30M , missing expectations by -18.53%.
Earnings released on 16 Mar 2023
EPS came in at $0.04 surpassing the estimated $0.01 by +300.00%, while revenue for the quarter reached $8.50M , beating expectations by +86.36%.
Earnings released on 10 Nov 2022
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $3.22M , beating expectations by +5.58%.
Earnings released on 11 Aug 2022
EPS came in at -$0.06 falling short of the estimated -$0.02 by -300.00%, while revenue for the quarter reached $7.36M , missing expectations by -5.67%.
Earnings released on 12 May 2022
EPS came in at -$0.21 falling short of the estimated -$0.08 by -162.50%, while revenue for the quarter reached $2.18M , beating expectations by +6.67%.
Earnings released on 16 Mar 2022
EPS came in at $0.04 falling short of the estimated $0.19 by -78.95%, while revenue for the quarter reached $6.09M .
Earnings released on 15 Nov 2021
EPS came in at -$0.24 falling short of the estimated -$0.14 by -71.43%, while revenue for the quarter reached $775.00K , beating expectations by +16.72%.
Earnings released on 16 Aug 2021
EPS came in at -$0.08 surpassing the estimated -$0.14 by +42.86%, while revenue for the quarter reached $3.07M , missing expectations by -35.57%.
Earnings released on 13 May 2021
EPS came in at $0.19 matching the estimated $0.19, while revenue for the quarter reached $11.90M , missing expectations by -1.27%.
Earnings released on 16 Mar 2021
EPS came in at -$0.32 falling short of the estimated -$0.26 by -23.08%, while revenue for the quarter reached $81.00K .
Earnings released on 12 Nov 2020
EPS came in at -$0.31 falling short of the estimated -$0.26 by -19.23%, while revenue for the quarter reached -$161.00K .
ETON Stock Performance
Access detailed ETON performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.